UK markets closed

Valbiotis SA (ALVAL.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
6.16-0.02 (-0.32%)
At close: 05:35PM CEST

Valbiotis SA

rue Paul Vatine
12th Floor ZI des Quatre Chevaliers
Périgny 17180
33 5 46 28 62 58

Full-time employees41

Key executives

NameTitlePayExercisedYear born
Mr. Sébastien PeltierCo-Founder, Chairman & CEON/AN/A1978
Mr. Jocelyn Pineau M.D.Co-Founder, CFO & DirectorN/AN/AN/A
Mr. Sebastien BessyChief Operating Marketing & Bus. Officer and DirectorN/AN/AN/A
Mr. Pascal Sirvent Ph.D.CSO & DirectorN/AN/AN/A
Ms. Murielle CazaubielCMO & DirectorN/AN/AN/A
Dr. Josep InfestaHead of Global Bus. Devel.N/AN/AN/A
Ms. Agnès TixierExec. Director of Credit Mutuel & Equity SCR and Member of Supervisory BoardN/AN/A1969
Mr. Philippe SibourChief Exec. Officer of Alliance ConsultingN/AN/AN/A
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


Valbiotis SA engages in the research and development of health nutrition products to prevent and combat metabolic and cardiovascular diseases. The company develops TOTUM-63 that is in Phase II/III clinical trials for the treatment of type 2 diabetes; TOTUM-070, which is in Phase II clinical trials to treat hypercholesterolemia; and TOTUM-854 that is in Phase II/III clinical trials for arterial hypertension. It also develops TOTUM-448 for the treatment of patient with non-alcoholic fatty liver disease. It has a strategic partnership with Nestlé Health Science. Valbiotis SA was incorporated in 2014 and is headquartered in Périgny, France.

Corporate governance

Valbiotis SA’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.